No abstract available
MeSH terms
-
Biomarkers
-
C-Reactive Protein / drug effects
-
Cardiovascular Diseases / prevention & control*
-
Drug Approval*
-
Fluorobenzenes / therapeutic use*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Primary Prevention / legislation & jurisprudence*
-
Pyrimidines / therapeutic use*
-
Risk Assessment
-
Rosuvastatin Calcium
-
Sulfonamides / therapeutic use*
-
United States
-
United States Food and Drug Administration*
Substances
-
Biomarkers
-
Fluorobenzenes
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Pyrimidines
-
Sulfonamides
-
Rosuvastatin Calcium
-
C-Reactive Protein